Schonfeld Strategic Advisors LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1665241 NEW YORK, NY

Back to NBIX Full portfolio

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$7,458,460

-$5,302,268 QoQ

Shares Held

56,615

-37.1% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

22 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Schonfeld Strategic Advisors LLC holds $50,240,980 across 18 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (14.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ANIP	Ani Pharmaceuticals Inc	185,629	$14,274,870
2	BCRX	Biocryst Pharmaceuticals Inc	1,337,693	$12,734,837
3	NBIX	Neurocrine Biosciences Inc This page	56,615	$7,458,460
4	UTHR	UNITED THERAPEUTICS Corp	4,290	$2,543,884
5	SUPN	Supernus Pharmaceuticals, Inc.	48,765	$2,520,662
6	KNSA	Kiniksa Pharmaceuticals International, plc	43,599	$2,099,291
7	ZTS	Zoetis Inc.	16,271	$1,923,394
8	XERS	Xeris Biopharma Holdings, Inc.	296,431	$1,719,299

All Filings in NBIX

Export CSV

22 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,458,460	56,615	-37.1%	Shares	Sole	2026-05-15
2025-12-31	$12,760,728	89,972	+15.8%	Shares	Sole	2026-02-17
2025-09-30	$10,906,543	77,693	+6.5%	Shares	Sole	2025-11-14
2025-06-30	$9,168,457	72,945	+918.4%	Shares	Sole	2025-08-14
2025-03-31	$792,227	7,163	-0.5%	Shares	Sole	2025-05-15
2024-12-31	$982,800	7,200	-70.3%	Shares	Sole	2025-02-14
2024-09-30	$2,797,772	24,282	-20.2%	Shares	Sole	2024-11-14
2024-06-30	$4,186,957	30,413	-36.2%	Shares	Sole	2024-08-14
2024-03-31	$6,577,956	47,694	-62.8%	Shares	Sole	2024-05-15
2023-12-31	$16,913,899	128,369	+342.5%	Shares	Sole	2024-02-14
2023-09-30	$3,263,512	29,009	-30.8%	Shares	Sole	2023-11-14
2023-06-30	$3,951,547	41,904	-55.5%	Shares	Sole	2023-08-14
2023-03-31	$9,531,077	94,162	+97.8%	Shares	Sole	2023-05-15
2022-12-31	$5,685,344	47,600	-31.5%	Shares	Sole	2023-02-14
2022-09-30	$7,375,541	69,443	+89.1%	Shares	Sole	2022-11-14
2022-06-30	$3,579,563	36,721	-50.2%	Shares	Sole	2022-08-15
2022-03-31	$6,910,031	73,707	-39.2%	Shares	Sole	2022-05-16
2021-12-31	$10,324,137	121,218	+512.2%	Shares	Sole	2022-02-14
2021-06-30	$1,926,936	19,800	-45.8%	Shares	Sole	2021-11-16
2020-09-30	$3,514,744	36,551	+637.1%	Shares	Sole	2020-11-19
2020-06-30	$604,998	4,959	+98.3%	Shares	Sole	2020-09-15
2020-03-31	$216,461	2,501	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.